Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients
BMJ
.
2020 Nov 11:371:m4362.
doi: 10.1136/bmj.m4362.
Author
Elisabeth Mahase
1
Affiliation
1
The BMJ.
PMID:
33177042
DOI:
10.1136/bmj.m4362
No abstract available